News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Remedent, Inc. (REMI.OB) Announces Fifth GlamSmile Studio in China


4/30/2013 12:13:20 PM

GHENT, BELGIUM--(Marketwired - April 30, 2013) - Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, announces that construction works are under way for the fifth GlamSmile Studio in China. Following the GlamSmile Studio's in Beijing, Shanghai, Wenzhou and Hong Kong, a new 600 m² / 6,453 ft² Studio in Guangzhou with 6 operational chairs is planned to open in the next quarter in the prestigious Guangzhou International Trading Building in CBD Area.

Guangzhou -- known historically as Canton -- is the third largest Chinese city with a little over 13 million people. It is a key national transportation hub and trading port, located 120 km northwest of Hong Kong and northeast of Macau.

Management Commentary:
"Pursuant to our Chinese bus plan and encouraged by yet another record quarter in China this opening in Guanzhou is very important in our strategy," comments Mr Guy De Vreese, CEO of Remedent. "It is our biggest most luxurious store to date with 6 chairs."

About Remedent:
Remedent Inc. creates state-of-the-art dental technologies and marketing concepts. Famous brands are GlamSmile, Remecure, White Boost, Formulation +, and River 8. Headquartered in Belgium, Remedent Inc. manufactures, markets and distributes its products and concepts to more than 25 countries worldwide. Remedent Inc. is publicly listed and focuses on B2B, delivering products to the dental professional, as well as B2C approaches, helping consumers to obtain their dream smile through its Smile Consultancy Concept.

Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q.


For more info, please contact:
Mr Luc Maes
Marketing Manager Remedent
Zuiderlaan 1-3 box 8, 9000 Gent - Belgium
T: +32-9-2415880
E: info@remedent.com
W: www.remedent.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES